[go: up one dir, main page]

SMT201700295T1 - Bacterial host strain expressing recombinant dsbc and having reduced tsp activity - Google Patents

Bacterial host strain expressing recombinant dsbc and having reduced tsp activity

Info

Publication number
SMT201700295T1
SMT201700295T1 SM20170295T SMT201700295T SMT201700295T1 SM T201700295 T1 SMT201700295 T1 SM T201700295T1 SM 20170295 T SM20170295 T SM 20170295T SM T201700295 T SMT201700295 T SM T201700295T SM T201700295 T1 SMT201700295 T1 SM T201700295T1
Authority
SM
San Marino
Prior art keywords
bacterial host
host strain
expressing recombinant
strain expressing
recombinant dsbc
Prior art date
Application number
SM20170295T
Other languages
Italian (it)
Inventor
Mark Ellis
David Paul Humphreys
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of SMT201700295T1 publication Critical patent/SMT201700295T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241Tumor Necrosis Factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/04Intramolecular oxidoreductases (5.3) transposing S-S bonds (5.3.4)
    • C12Y503/04001Protein disulfide-isomerase (5.3.4.1), i.e. disufide bond-forming enzyme
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SM20170295T 2010-01-14 2011-01-13 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity SMT201700295T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1000591.6A GB201000591D0 (en) 2010-01-14 2010-01-14 Bacterial hoist strain
PCT/EP2011/050416 WO2011086139A1 (en) 2010-01-14 2011-01-13 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity
EP11701045.4A EP2523969B1 (en) 2010-01-14 2011-01-13 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity

Publications (1)

Publication Number Publication Date
SMT201700295T1 true SMT201700295T1 (en) 2017-07-18

Family

ID=42028361

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20170295T SMT201700295T1 (en) 2010-01-14 2011-01-13 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity

Country Status (23)

Country Link
US (2) US8969038B2 (en)
EP (1) EP2523969B1 (en)
JP (1) JP5960608B2 (en)
KR (1) KR101729361B1 (en)
CN (2) CN104328079A (en)
AU (2) AU2011206587A1 (en)
CA (1) CA2786336C (en)
CY (1) CY1118990T1 (en)
DK (1) DK2523969T3 (en)
ES (1) ES2627826T3 (en)
GB (1) GB201000591D0 (en)
HK (1) HK1206785A1 (en)
HR (1) HRP20170852T1 (en)
HU (1) HUE033555T2 (en)
LT (1) LT2523969T (en)
ME (1) ME02752B (en)
PL (1) PL2523969T3 (en)
PT (1) PT2523969T (en)
RS (1) RS56159B1 (en)
SG (1) SG182280A1 (en)
SI (1) SI2523969T1 (en)
SM (1) SMT201700295T1 (en)
WO (1) WO2011086139A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE040306T2 (en) 2009-09-24 2019-03-28 Ucb Biopharma Sprl Bacterial strain for expression of recombinant protein containing protease-deficient but chaperon-active DEGP and gene-cleaved TSP and PTR genes
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EA031449B1 (en) 2011-07-13 2019-01-31 Юсб Фарма, С.А. BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DsbC
EP2546267A1 (en) * 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
US11306328B2 (en) 2013-07-26 2022-04-19 President And Fellows Of Harvard College Genome engineering
US10358460B2 (en) 2014-12-22 2019-07-23 Ucb Biopharma Sprl Protein manufacture
BR112018015259A2 (en) 2016-01-27 2018-12-18 Medimmune Llc Methods for preparing antibodies with a defined glycosylation standard
EP4467565A3 (en) 2016-12-21 2025-03-12 Amgen Inc. Anti-tnf alpha antibody formulations
WO2019193418A1 (en) 2018-04-05 2019-10-10 Bio-Rad Abd Serotec Gmbh Display systems for proteins of interest
SG11202104104VA (en) * 2018-11-05 2021-05-28 Genentech Inc Methods of producing two chain proteins in prokaryotic host cells
EP3942079A1 (en) 2019-03-18 2022-01-26 Bio-Rad ABD Serotec GmbH Protection of spytag-containing periplasmic fusion proteins from protease tsp and ompt degradation
PL4010500T3 (en) * 2019-08-05 2025-06-23 Wacker Chemie Ag Bacterial strain for releasing a recombinant protein in a fermentation method

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
AU2660397A (en) 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
JP2000083670A (en) 1998-09-09 2000-03-28 Hsp Kenkyusho:Kk Dsba/dsbb/dsbc/dsbd-expression plasmid
CA2377491C (en) 1999-06-29 2008-01-29 Siga Technologies, Inc. Assay for degp protease inhibitors
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
EP1314037A2 (en) 2000-09-01 2003-05-28 Biogen, Inc. Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
DK1341899T3 (en) 2000-12-14 2006-04-10 Genentech Inc Bacterial Host Strains
CA2430182C (en) * 2000-12-14 2011-01-25 Genentech, Inc. Prokaryotically produced antibodies and uses thereof
WO2004081026A2 (en) 2003-06-30 2004-09-23 Domantis Limited Polypeptides
TWI327597B (en) 2001-08-01 2010-07-21 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
DE60224291T2 (en) * 2001-08-27 2008-12-11 Genentech, Inc., South San Francisco SYSTEM FOR ANTIBODY EXPRESSION AND SYNTHESIS
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
IL161988A0 (en) 2001-11-16 2005-11-20 Corporation Idec Pharmaceutica Polycistronic expression of antibodies
GB0129105D0 (en) 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
AU2003244817B2 (en) 2002-06-28 2010-08-26 Domantis Limited Antigen-binding immunoglobulin single variable domains and dual-specific constructs
GB0224082D0 (en) 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
EP1578447A4 (en) 2002-10-31 2009-06-03 Genentech Inc METHODS AND COMPOSITIONS THAT CAN INCREASE ANTIBODY PRODUCTION
PT1570267E (en) 2002-12-03 2012-01-03 Ucb Pharma Sa Assay for identifying antibody producing cells
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
CA2528551A1 (en) 2003-06-13 2005-01-13 Biogen Idec Ma Inc. Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
AU2004261198A1 (en) 2003-07-26 2005-02-10 Biogen Idec Ma Inc. Altered antibodies having improved antigen-binding affinity
JP5102028B2 (en) 2004-07-26 2012-12-19 バイオジェン・アイデック・エムエイ・インコーポレイテッド Anti-CD154 antibody
US20060204493A1 (en) * 2004-09-02 2006-09-14 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0520169D0 (en) 2005-10-04 2005-11-09 Celltech R&D Ltd Biological products
BRPI0809042B1 (en) 2007-03-22 2021-08-31 Biogen Ma Inc. ISOLATED CD154-BINDING PROTEIN, ITS USE, AND COMPOSITION
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
HUE040306T2 (en) 2009-09-24 2019-03-28 Ucb Biopharma Sprl Bacterial strain for expression of recombinant protein containing protease-deficient but chaperon-active DEGP and gene-cleaved TSP and PTR genes
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
CA2780143A1 (en) 2009-11-05 2011-05-12 Genentech, Inc. Methods and composition for secretion of heterologous polypeptides
GB201000588D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000591D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
EA031449B1 (en) 2011-07-13 2019-01-31 Юсб Фарма, С.А. BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DsbC
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Also Published As

Publication number Publication date
CN102712679A (en) 2012-10-03
US8969038B2 (en) 2015-03-03
ME02752B (en) 2018-01-20
SI2523969T1 (en) 2017-07-31
US20120288894A1 (en) 2012-11-15
CA2786336C (en) 2018-09-04
JP5960608B2 (en) 2016-08-02
AU2017202434A1 (en) 2017-05-04
CA2786336A1 (en) 2011-07-21
KR101729361B1 (en) 2017-04-21
BR112012016808A2 (en) 2017-06-27
AU2017202434B2 (en) 2019-05-16
CN102712679B (en) 2015-06-03
CN104328079A (en) 2015-02-04
ES2627826T3 (en) 2017-07-31
CY1118990T1 (en) 2018-01-10
JP2013516966A (en) 2013-05-16
US9493559B2 (en) 2016-11-15
HK1206785A1 (en) 2016-01-15
HUE033555T2 (en) 2017-12-28
RS56159B1 (en) 2017-11-30
AU2011206587A1 (en) 2012-07-19
EP2523969A1 (en) 2012-11-21
LT2523969T (en) 2017-06-26
PT2523969T (en) 2017-07-04
US20150166652A1 (en) 2015-06-18
WO2011086139A1 (en) 2011-07-21
KR20120115997A (en) 2012-10-19
PL2523969T3 (en) 2017-09-29
DK2523969T3 (en) 2017-06-12
HRP20170852T1 (en) 2017-08-25
EP2523969B1 (en) 2017-03-22
GB201000591D0 (en) 2010-03-03
SG182280A1 (en) 2012-08-30
HK1176943A1 (en) 2013-08-09

Similar Documents

Publication Publication Date Title
SI2523969T1 (en) Bacterial host strain expressing recombinant dsbc and having reduced tsp activity
IL229947B (en) Bacterial host strain expressing recombinant dsbc
ZA201300147B (en) Recombinant host cells comprising phosphoketolases
PT2524043E (en) Bacterial host strain comprising a mutant spr gene and having reduced tsp activity
EP2569712A4 (en) Control system user interface
EP2569436B8 (en) Recombinant hcmv and rhcmv vectors and uses thereof
GB2494792B (en) Subsea orientation and control system
GB2480940B (en) Well control systems and methods
PL2655644T3 (en) Improving fermentation processes and by-products
SG10201503428RA (en) Data Gathering System
EP2531099A4 (en) Data gathering system
SI2523975T1 (en) Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene
SG10201606462WA (en) Bacterial host strain
EP2551757A4 (en) Information interaction method and interface control system
AU2011233911A1 (en) Dishwasher and control method thereof
EP2612298A4 (en) Co-compression and co-decompression of data values
EP2540175A4 (en) Soft and elastic jacket
GB201000589D0 (en) Bacterial host strain
GB201000605D0 (en) Bacterial host strain
GB201000606D0 (en) Bacterial host strain
GB0916822D0 (en) Bacterial host strain
GB0916818D0 (en) Bacterial host strain
GB0916817D0 (en) Bacterial host strain
GB0916821D0 (en) Bacterial host strain
GB0922070D0 (en) Improved product assembly system and control software